FDA Inspection 1173378 — WellSky Corporation
The FDA completed an inspection of WellSky Corporation on June 16, 2022 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Overland Park, KS (United States)